ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424 | -4.5% | 20,348 | +9.8% | 0.05% | -43.2% |
| Q2 2023 | $444 | +37.5% | 18,535 | +8.1% | 0.08% | +84.1% |
| Q1 2023 | $323 | -25.7% | 17,142 | -37.2% | 0.04% | -33.3% |
| Q4 2022 | $435 | -99.9% | 27,316 | +48.4% | 0.07% | +43.5% |
| Q3 2022 | $301,000 | -14.0% | 18,401 | -25.9% | 0.05% | -25.8% |
| Q2 2022 | $350,000 | -15.3% | 24,834 | +45.5% | 0.06% | -8.8% |
| Q1 2022 | $413,000 | -15.9% | 17,072 | -18.9% | 0.07% | -19.0% |
| Q4 2021 | $491,000 | +3.6% | 21,048 | -26.3% | 0.08% | +47.4% |
| Q3 2021 | $474,000 | -17.0% | 28,553 | +21.9% | 0.06% | -13.6% |
| Q2 2021 | $571,000 | -16.4% | 23,417 | -11.5% | 0.07% | -45.5% |
| Q1 2021 | $683,000 | -49.9% | 26,456 | +3.9% | 0.12% | -26.7% |
| Q4 2020 | $1,362,000 | – | 25,468 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |